Merck Income After Taxes 2010-2024 | MKKGY
Merck annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Merck income after taxes for the quarter ending June 30, 2024 was $0.652B, a 15.37% decline year-over-year.
- Merck income after taxes for the twelve months ending June 30, 2024 was $2.850B, a 11.69% decline year-over-year.
- Merck annual income after taxes for 2023 was $3.067B, a 12.81% decline from 2022.
- Merck annual income after taxes for 2022 was $3.518B, a 2.98% decline from 2021.
- Merck annual income after taxes for 2021 was $3.626B, a 59.28% increase from 2020.
Merck Annual Income After Taxes
(Millions of US $) |
| 2023 |
$3,067 |
| 2022 |
$3,518 |
| 2021 |
$3,626 |
| 2020 |
$2,277 |
| 2019 |
$1,450 |
| 2018 |
$1,291 |
| 2017 |
$2,950 |
| 2016 |
$1,807 |
| 2015 |
$1,241 |
| 2014 |
$1,548 |
| 2013 |
$1,606 |
| 2012 |
$745 |
| 2011 |
$876 |
| 2010 |
$12,338 |
| 2009 |
$10,807 |
Merck Quarterly Income After Taxes
(Millions of US $) |
| 2024-06-30 |
$652 |
| 2024-03-31 |
$759 |
| 2023-12-31 |
$634 |
| 2023-09-30 |
$805 |
| 2023-06-30 |
$770 |
| 2023-03-31 |
$858 |
| 2022-12-31 |
$667 |
| 2022-09-30 |
$933 |
| 2022-06-30 |
$926 |
| 2022-03-31 |
$992 |
| 2021-12-31 |
$923 |
| 2021-09-30 |
$901 |
| 2021-06-30 |
$900 |
| 2021-03-31 |
$902 |
| 2020-12-31 |
$510 |
| 2020-09-30 |
$943 |
| 2020-06-30 |
$318 |
| 2020-03-31 |
$505 |
| 2019-12-31 |
$374 |
| 2019-09-30 |
$377 |
| 2019-06-30 |
$473 |
| 2019-03-31 |
$226 |
| 2018-12-31 |
$204 |
| 2018-09-30 |
$376 |
| 2018-06-30 |
$291 |
| 2018-03-31 |
$420 |
| 2017-12-31 |
$1,165 |
| 2017-09-30 |
$763 |
| 2017-06-30 |
$465 |
| 2017-03-31 |
$557 |
| 2016-12-31 |
$285 |
| 2016-09-30 |
$513 |
| 2016-06-30 |
$355 |
| 2016-03-31 |
$654 |
| 2015-12-31 |
$130 |
| 2015-09-30 |
$407 |
| 2015-06-30 |
$382 |
| 2015-03-31 |
$322 |
| 2014-12-31 |
$349 |
| 2014-09-30 |
$331 |
| 2014-06-30 |
$420 |
| 2014-03-31 |
$449 |
| 2013-12-31 |
$384 |
| 2013-09-30 |
$454 |
| 2013-06-30 |
$413 |
| 2013-03-31 |
$355 |
| 2012-12-31 |
$3,646 |
| 2012-09-30 |
$236 |
| 2012-06-30 |
$-78 |
| 2012-03-31 |
$3,274 |
| 2011-12-31 |
$3,311 |
| 2011-09-30 |
$3,585 |
| 2011-06-30 |
$-121 |
| 2011-03-31 |
$3,505 |
| 2010-12-31 |
$6,575 |
| 2010-09-30 |
$277 |
| 2010-06-30 |
$2,695 |
| 2010-03-31 |
$2,791 |
| 2009-12-31 |
$2,983 |
| 2009-09-30 |
$2,778 |
| 2009-06-30 |
$2,590 |
| 2009-03-31 |
$2,456 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
